Chancellor Rachel Reeves Aims for Specific Action on Household Expenses in Forthcoming Financial Plan

Chancellor Rachel Reeves has stated she is preparing "specific measures to deal with household expense issues" in next month's Budget.

In comments to the BBC, she noted that lowering price rises is a collective duty of both the government and the central bank.

The United Kingdom's inflation rate is projected to be the most elevated among the G7 industrialized countries this calendar year and next.

Potential Energy Bill Measures

Reports indicate the administration could intervene to reduce energy bills, for example by reducing the current 5% level of value-added tax applied on energy.

An additional possibility is to lower some of the government charges currently included in bills.

Fiscal Constraints and Expert Expectations

The government will receive the next draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for such measures.

The consensus from most economists is that the Chancellor will have to introduce tax rises or budget cuts in order to meet her declared fiscal targets.

Earlier on Thursday, estimates suggested there was a £22 billion shortfall for the chancellor to resolve, which is at the lower end of forecasts.

"There's a collective responsibility between the Bank of England and the administration to bear down further on some of the causes of price increases," the Chancellor stated to reporters in Washington, at the annual meetings of the IMF and global financial institution.

Tax Commitments and International Concerns

While much of the focus has been on expected tax rises, the Treasury chief said the latest figures from the OBR had not changed her vow to election pledges not to raise rates on income tax, sales tax or National Insurance.

She attributed an "unpredictable world" with growing geopolitical and commercial issues for the Budget revenue measures, likely to be directed on those "most able to pay."

Global Economic Disputes

Commenting on worries about the UK's trade ties with China she said: "The UK's national security always are paramount."

Last week's statement by Chinese authorities to tighten trade restrictions on critical minerals and other resources that are crucial for advanced tech production led American leader Donald Trump to threaten an further 100% tariff on imports from the Asian country, raising the possibility of an full-scale trade war between the two largest economies.

The US Treasury Secretary labeled the Chinese decision "commercial pressure" and "a international production control attempt."

Asked about considering the US offer to join its conflict with the Asian nation, Reeves said she was "deeply worried" by China's measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the action was "bad for the international commerce and generates further headwinds."

"It is my opinion there are areas where we must confront Chinese policies, but there are also valuable chances to export to Chinese markets, including financial services and other areas of the economy. We've got to maintain that balance correct."

The chancellor also affirmed she was cooperating with international partners "on our own critical minerals approach, so that we are reduced dependence."

Health Service Medicine Costs and Investment

Reeves also admitted that the price the National Health Service pays for medicines could rise as a consequence of current negotiations with the US government and its pharmaceutical firms, in return for lower tariffs and capital.

Some of the world's largest drug companies have said in recent statements that they are either delaying or canceling projects in the United Kingdom, with some attributing the modest returns they are receiving.

Recently, the Science Minister said the cost the health service spends on medicines would must rise to prevent companies and pharmaceutical investment leaving the United Kingdom.

Reeves stated to media: "It has been observed because of the cost structure, that medical research, recent pharmaceuticals have not been offered in the UK in the manner that they are in other EU nations."

"Our aim is to make sure that patients receiving care from the National Health Service are can receive the finest essential medicines in the globe. And so we are reviewing all of that, and... aiming to attract increased investment into the UK."